ACTRN12608000050358
Recruiting
未知
A double blind randomized controlled trial to investigate laser and sham laser on auricular and body acupuncture points to assist in smoking cessation
Dr Christopher Zaslawski0 sites120 target enrollmentJanuary 29, 2008
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Dr Christopher Zaslawski
- Enrollment
- 120
- Status
- Recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Adults who are smokers. Adults who wish to give up smoking. Adults who can understand the consent form and agree to treatment and can read and write sufficiently to read and answer the questionnaires.
Exclusion Criteria
- •Adults who have uncontrolled diabetes mellitus, ischemic heart disease, unstable epilepsy or asthma or are pregnant.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 2
A double-blind randomized placebo controlled trial to investigate the effectiveness and safety of Retinyl Palmitate in patients with chronic Achilles tendinopathyAchilles tendinopathySLCTR/2023/016Regenall (UK)
Suspended
Phase 3
Hepatitis B vaccine in patients with chronic kidney diseaseHealth Condition 1: N183- Chronic kidney disease, stage 3 (moderate)Health Condition 2: N184- Chronic kidney disease, stage 4 (severe)CTRI/2022/07/044007Indian Council of Medical Research ICMR
Active, not recruiting
Not Applicable
sefulness and safety of Mw vaccine versus Mantoux antigen in patients of warts caused by virusHealth Condition 1: null- Multiple viral wartsCTRI/2017/08/009327Medical College Kolkata
Completed
Not Applicable
Clinical trial with fermented milk drink on functional constipatioISRCTN78807934Yakult Honsha Co. Ltd100
Recruiting
Not Applicable
A double-blind randomized controlled trial to verify the improvement effect of Hangeshashinto on oral mucositis and blood metabolome analysis to clarify biomarkers, Kampo medicine's proof, and to contribute to appropriate use of Kampo medicinesHead and Neck cancerJPRN-UMIN000049103ational Cancer Center Hospital Department of Dentistry70